These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 2476617)
1. Acute electrophysiologic effects and antiarrhythmic/antifibrillatory activity of intravenous amiodarone in a chronic feline infarction model. Marinchak RA; O'Connor KM; Friehling TD; Kowey PR J Cardiovasc Pharmacol; 1989 Sep; 14(3):389-95. PubMed ID: 2476617 [TBL] [Abstract][Full Text] [Related]
2. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy. Anderson JL Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079 [TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic effect of chronic oral amiodarone treatment in dogs with myocardial infarction and reproducibly inducible sustained ventricular arrhythmias. Abdollah H; Brien JF; Brennan FJ J Cardiovasc Pharmacol; 1990 May; 15(5):799-807. PubMed ID: 1692941 [TBL] [Abstract][Full Text] [Related]
4. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction. Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590 [TBL] [Abstract][Full Text] [Related]
6. Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted in anesthetized dogs. D'Alonzo AJ; Sewter JC; Darbenzio RB; Hess TA Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):222-8. PubMed ID: 7477447 [TBL] [Abstract][Full Text] [Related]
7. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666 [TBL] [Abstract][Full Text] [Related]
8. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction. Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937 [TBL] [Abstract][Full Text] [Related]
9. Ibutilide Reduces Ventricular Defibrillation Threshold and Organizes Ventricular Fibrillation Activation in Canine Heart Failure Model. Zhang N; Luo Q; Jin Q; Han Y; Huang S; Wei Y; Lin C; Chen K; Shen W; Wu L Cardiovasc Drugs Ther; 2020 Jun; 34(3):323-334. PubMed ID: 32297025 [TBL] [Abstract][Full Text] [Related]
10. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction. Morady F; DiCarlo LA; Krol RB; Baerman JM; de Buitleir M J Am Coll Cardiol; 1986 Jan; 7(1):148-57. PubMed ID: 3941203 [TBL] [Abstract][Full Text] [Related]
12. Effects of the potassium channel blocking agent ambasilide on ventricular arrhythmias induced by acute myocardial ischemia and sympathetic activation. Stramba-Badiale M; Pessano P; Kirchengast M; Schwartz PJ Am Heart J; 1995 Mar; 129(3):549-56. PubMed ID: 7872187 [TBL] [Abstract][Full Text] [Related]
13. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy]. Gülker H; Thale J Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228 [TBL] [Abstract][Full Text] [Related]
14. The effect of beta-adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models. Luketich J; Friehling TD; O'Connor KM; Kowey PR Am Heart J; 1989 Aug; 118(2):265-71. PubMed ID: 2750648 [TBL] [Abstract][Full Text] [Related]
15. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model. Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022 [TBL] [Abstract][Full Text] [Related]
16. Relationship between myocardial amiodarone concentration and antiarrhythmic effect in dogs with myocardial infarction and electrically induced ventricular arrhythmias. Abdollah H; Brennan FJ; Jimmo S; Brien JF Can J Physiol Pharmacol; 1991 Jun; 69(6):812-7. PubMed ID: 1913327 [TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models. Kopia GA; Eller BT; Patterson E; Shea MJ; Lucchesi BR Eur J Pharmacol; 1985 Oct; 116(1-2):49-61. PubMed ID: 4054216 [TBL] [Abstract][Full Text] [Related]
18. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug. Black SC; Butterfield JL; Lucchesi BR J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898 [TBL] [Abstract][Full Text] [Related]
19. Dose-Dependent Effects of Ranolazine on Reentrant Ventricular Arrhythmias Induced After Subacute Myocardial Infarction in Rabbits. Moschovidis V; Simopoulos V; Stravela S; Dipla K; Hatziefthimiou A; Stamatiou R; Aidonidis I J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):65-71. PubMed ID: 31242756 [TBL] [Abstract][Full Text] [Related]
20. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. Finance O; Manning A; Chatelain P J Cardiovasc Pharmacol; 1995 Oct; 26(4):570-6. PubMed ID: 8569217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]